Clinical Trials Logo

Recurrent Vestibulopathy clinical trials

View clinical trials related to Recurrent Vestibulopathy.

Filter by:
  • None
  • Page 1

NCT ID: NCT04026516 Suspended - Clinical trials for Benign Paroxysmal Positional Vertigo

CAVA: Dizziness Trial

CAVA
Start date: July 1, 2019
Phase: N/A
Study type: Interventional

Clinical investigation of a medical device (CAVA) for recording eye movements. Patients suffering from diagnosed dizziness conditions will wear the device for 23 hours a day, for 30 days. The device will capture normal eye movement data as well as data corresponding to any dizzy events experienced. At the end of the trial, the data will be downloaded and a scientist will perform a blinded analysis of the data. Specifically, they will attempt to identify the dates on which dizziness was reported.

NCT ID: NCT01895400 Terminated - Clinical trials for Recurrent Vestibulopathy

Effect of Renexin Tablet in Patients With Recurrent Vestibulopathy

REREV
Start date: July 2013
Phase: Phase 3
Study type: Interventional

The purpose of this study is to determine whether Renexin is effective in the treatment of vestibular symptoms in patients with recurrent vestibulopathy.